AI
TMCI icon

Accredited Investors’s Treace Medical Concepts TMCI Stock Holding History

Accredited Investors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,000
Closed -$588K – 271
2025
Q2 		$588K Hold
100,000
– – 0.03% 130
2025
Q1 		$839K Hold
100,000
– – 0.05% 100
2024
Q4 		$744K Buy
100,000
+31,000
+45% +$207K 0.04% 106
2024
Q3 		$400K Hold
69,000
– – 0.02% 151
2024
Q2 		$459K Buy
+69,000
New +$557K 0.03% 128

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Accredited Investors's TMCI Position: Q3 2025 in Review

Accredited Investors sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 100,000 shares — an estimated $588K sold.

Accredited Investors first reported a position in TMCI in Q2 2024 and held it in 5 quarters. The position peaked at $839K in Q1 2025. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Accredited Investors reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Accredited Investors sold 100,000 Treace Medical Concepts shares in Q3 2025, an estimated $588K.
  • Accredited Investors first reported a position in Treace Medical Concepts in Q2 2024 and held it in 5 quarters.
  • Accredited Investors's Treace Medical Concepts position peaked at $839K in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Accredited Investors's 13F filing for Q3 2025, filed 30 Oct 2025.